Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 153 EP applications Nicholas Robert Sutcliffe has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 10, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12712344

TREATMENT FOR PEANUT ALLERGY

IPC classification:
A61K 39/35
Applicant:
Cambridge University Hospitals NHS Foundation Trust
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12718729

CELLULAR SUBSTRATE FOR NUCLEAR REPROGRAMMING

IPC classification:
C12N 5/078
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The patent has been granted
EP12776706

PRODUCTION AND DELIVERY OF A STABLE COLLAGEN

IPC classification:
A61K 31/195, A01N 37/44, A01N 37/12
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Applicant:
Department of Veterans Affairs - Office of the General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12728115

POPULATIONS OF SMOOTH MUSCLE CELLS OF SPECIFIC EMBRYONIC LINEAGES

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12735365

METHODS FOR PREPARATIVE IN VITRO CLONING

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12822010

IMMUNOGENIC COMPOSITIONS AND METHODS THEREFOR

IPC classification:
A61K 39/21, A61K 39/155, A61K 39/145, A61K 39/09, C12N 15/62, A61P 31/22
Applicant:
The University of Queensland
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12827124

VACCINE PREPARATION FOR CANCER TREATMENT

IPC classification:
A61K 47/48, A61K 47/36, A61K 45/00, A61K 39/12, A61K 39/00, C12N 15/117, C07K 19/00, C07K 14/00, A61P 35/00, A61P 31/12
Applicant:
Tokyo Medical and Dental University
Applicant:
Mie University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12833767

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/00, C12P 21/08, C07K 16/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12838386

PI-KINASE INHIBITORS WITH BROAD SPECTRUM ANTI-INFECTIVE ACTIVITY

IPC classification:
A01N 43/00
Applicant:
University of California
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12845990

MATERIAL HAVING PORES ON SURFACE, AND METHOD FOR MANUFACTURING SAME

IPC classification:
A61L 27/00, A61L 17/00, C22C 14/00, C08J 9/36, C08J 9/00, C04B 41/91, B24C 11/00, B24C 1/06
Applicant:
Kyoto University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12850629

HUMAN NOTCH RECEPTOR MUTATIONS AND THEIR USE

IPC classification:
G01N 33/48, C07H 21/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12729620

PROCESS FOR MAKING CHITIN DERIVATIVES

IPC classification:
C12P 19/04
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
GRANT OF PATENT INTENDED
EP12730912

COMPOSITION COMPRISING CHITOSAN, GLUCOSAMINE AND AMINO ACIDS FOR AGRICULTURAL USE

IPC classification:
A01P 15/00, A01P 5/00, A01P 3/00, A01N 63/02, A01N 43/16, A01N 37/44
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
EXAMINATION IN PROGRESS
EP12774375

iPS CELL HAVING DIFFERENTIATION PROPENSITY FOR CORNEAL EPITHELIUM

IPC classification:
C12N 5/10, C12N 5/079, C12N 5/074, C12N 5/0735, C12N 5/071
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733927

ANALYSIS AND TARGETING OF ROR2 IN CANCER

IPC classification:
G01N 33/574
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13738232

HIGH AFFINITY SIRP-ALPHA REAGENTS

IPC classification:
A61K 38/16
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12868058

CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS

IPC classification:
A61K 39/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12771088

IMPROVED CATALYST FOR THERMOCATALYTIC CONVERSION OF BIOMASS TO LIQUID FUELS AND CHEMICALS

IPC classification:
C10G 3/00, B01J 29/40
Applicant:
KiOR Inc
Agent:
Phillip Brian Lucas, Lucas & Co.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12856612

STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION

IPC classification:
C12N 5/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12754339

PHYLLOSILICATE-BASED COMPOSITIONS AND METHODS OF MAKING THE SAME FOR CATALYTIC PYROLYSIS OF BIOMASS

IPC classification:
C10G 3/00, C10G 1/08, B01J 37/00, B01J 20/00
Applicant:
KiOR Inc
Agent:
Phillip Brian Lucas, Lucas & Co.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764988

TREATMENT OF PULMONARY HYPERTENSION WITH LEUKOTRIENE INHIBITORS

IPC classification:
A61K 31/4015, A61K 31/165, A61P 9/12
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12830223

TOPICAL ITRACONAZOLE FORMULATIONS AND USES THEREOF

IPC classification:
A61K 47/40, A61K 47/32, A61K 47/26, A61K 47/14, A61K 47/10, A61K 31/496, A61P 35/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12814264

RSPO BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 45/06, A61K 39/395, A61K 38/17, G01N 33/574, C07K 16/46, C07K 16/30, C07K 16/28, C07K 16/18, C07K 14/71, A61P 35/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12800695

METHODS FOR INCREASING INSULIN SENSITIVITY AND TREATING DIABETES

IPC classification:
A61K 38/48, A61K 38/43, A61K 38/00, G01N 33/50, C12Q 1/37, C12Q 1/00, C12N 9/64, C12N 9/00, A61P 5/50, A61P 3/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13781751

GEL WITH SELF-RESTORABILITY AND SHAPE-MEMORY PROPERTY AND PROCESS FOR PRODUCING SAME

IPC classification:
C08F 220/54, C08F 220/10, C08F 2/10
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13790284

METHODS FOR TREATING CANCER WITH NOTCH2/3 ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13740741

THERAPEUTIC IL-13 POLYPEPTIDES

IPC classification:
A61K 38/00, C07K 1/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13788066

METHODS AND COMPOSITIONS FOR PROVIDING A PREECLAMPSIA ASSESSMENT

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733195

CURCUMIN DERIVATIVES FOR MICROBIAL BIOFILM DESTRUCTION

IPC classification:
A61K 31/12, A01N 35/02, A61P 31/04
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13734473

TRANSCRIPTION FACTOR MEDIATED PROGRAMMING TOWARDS MEGAKARYOCYTES

IPC classification:
A61K 31/14, C12N 5/0789, C12N 5/078
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13809969

METHODS FOR NUCLEIC ACID ASSEMBLY AND HIGH THROUGHPUT SEQUENCING

IPC classification:
C40B 50/06
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12837648

METHOD FOR RECOGNITION OF SPEECH MESSAGES AND DEVICE FOR CARRYING OUT THE METHOD

IPC classification:
G10L 21/028, G10L 21/0208, G10L 17/00, G10L 15/18, G10L 15/08, G10L 15/04
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12734424

ENHANCEMENT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

IPC classification:
A61P 35/00, A61K 35/28, C12N 5/0783, A61K 35/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The patent has been granted
EP13837673

STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION

IPC classification:
A61K 38/24, A61K 38/00
Applicant:
The Intellectual Property Management Center in the St. Mariana University School of Medicine
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13765696

IN VITRO PANCREATIC DIFFERENTIATION OF PLURIPOTENT MAMMALIAN CELLS

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13839746

METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES WITH NOTCH1 ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/02, A61P 35/00, A61N 5/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13848322

METHODS OF TREATING NEUROENDOCRINE TUMORS USING WNT PATHWAY-BINDING AGENTS

IPC classification:
A61K 39/395, C12N 15/11
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13851541

METHODS AND MONITORING OF TREATMENT WITH A DLL4 ANTAGONIST

IPC classification:
G01N 33/53
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14199035

Notch-binding agents and antagonists and methods of use thereof

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15159715

COMPOSITIONS AND METHODS FOR HIGH FIDELITY ASSEMBLY OF NUCLEIC ACIDS

IPC classification:
G06F 19/10, C40B 50/06, C12P 19/34, C12N 15/66, C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15170734

TARGETING OF BONE MARROW NEOVASCULATURE

IPC classification:
A61K 39/395, C07K 16/18, A61P 35/02
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14746505

METHODS AND MONITORING OF TREATMENT WITH A WNT PATHWAY INHIBITOR

IPC classification:
A61P 19/08
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14763776

DESETHYLHYDROXYCHLOROQUINE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATION

IPC classification:
A61K 31/505, A01N 43/54
Applicant:
Department of Veterans Affairs - Office of the General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14770132

METHODS FOR ANALYZING NUCLEIC ACIDS

IPC classification:
C12P 19/34, C12Q 1/68
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13877452

AN INTEGRATED SYSTEM FOR LIBRARY CONSTRUCTION, AFFINITY BINDER SCREENING AND EXPRESSION THEREOF

IPC classification:
C12N 15/80, C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14773248

COMPOSITIONS, METHODS AND APPARATUS FOR OLIGONUCLEOTIDES SYNTHESIS

IPC classification:
C40B 50/14, C40B 40/06, C12P 19/34
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14780166

METHODS AND COMPOSITIONS FOR INHIBITING THE EFFECTS OF AMYLOID BETA OLIGOMERS

IPC classification:
C07K 17/00, C07K 14/00, C07K 1/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14770177

SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM

IPC classification:
C12M 3/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765235

MICROFLUIDIC METHODS FOR MANIPULATING DNA

IPC classification:
C12N 15/10, G01N 33/00, G01N 27/447, G01N 27/26, C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14769872

COMPOSITIONS AND METHODS FOR MULTIPLEX NUCLEIC ACIDS SYNTHESIS

IPC classification:
C12P 19/34, C07H 21/04, C07H 21/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14782093

CROSSLINKED CHITOSAN-LACTIDE HYDROGELS

IPC classification:
A61K 47/48
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15177553

METHODS AND DEVICES FOR NUCLEIC ACIDS SYNTHESIS

IPC classification:
C12P 19/34, C12N 15/66, C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The patent has been granted
EP15178099

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER

IPC classification:
A61P 35/00, C12N 15/12, C07K 14/475, C07K 14/705, C07K 16/28, A61K 39/395
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14834669

METHODS OF TREATMENT OF HPV RELATED DISEASES

IPC classification:
A61P 31/20, A61P 35/00, A61K 39/12
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14749749

METHODS OF MODULATING SEED AND ORGAN SIZE IN PLANTS

IPC classification:
C12N 15/82, A61K 38/53, C07K 14/415
Applicant:
Plant Bioscience Limited
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14837955

METHODS AND SYSTEMS FOR ALIGNING SEQUENCES

IPC classification:
G01N 33/50, G01N 33/574, C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14842846

METHODS AND COMPOSITIONS FOR SELECTIVE AND TARGETED CANCER THERAPY

IPC classification:
A61P 35/00, A61K 31/428, A61K 31/426
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14850811

T CELL-INDUCING VACCINE CONTAINING INTEREPITOPE SEQUENCE PROMOTING ANTIGEN PRESENTATION

IPC classification:
C07K 14/00, A61P 35/00, A61P 31/12, A61P 31/04, A61K 48/00, A61K 47/36, A61K 39/00
Applicant:
Kyoto University
Applicant:
Mie University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14847490

METHODS AND SYSTEM FOR DETECTING SEQUENCE VARIANTS

IPC classification:
C40B 60/12, C40B 40/06, C12Q 1/68, G06F 19/22
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14853307

METHODS FOR ASSESSING A GENOMIC REGION OF A SUBJECT

IPC classification:
C40B 30/04, C07H 21/02, C12P 19/34, C12Q 1/68
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14854801

METHODS AND SYSTEMS FOR GENOTYPING GENETIC SAMPLES

IPC classification:
G01N 1/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14803268

METHODS AND SYSTEMS FOR IDENTIFYING DISEASE-INDUCED MUTATIONS

IPC classification:
C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14789740

SYSTEMS AND METHODS FOR USING PAIRED-END DATA IN DIRECTED ACYCLIC STRUCTURE

IPC classification:
G06F 19/22
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14781860

IN VITRO PRODUCTION OF FOREGUT STEM CELLS

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14857169

PAIN RELIEF FORMULATION AND METHOD OF TREATMENT

IPC classification:
A61K 31/045, A61K 31/165, A61K 36/38, A61K 36/61
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14802104

METHODS OF MODULATING SEED AND ORGAN SIZE IN PLANTS

IPC classification:
C12N 15/82, C07K 14/415
Applicant:
Plant Bioscience Limited
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP16155324

THERAPEUTIC COMBINATION AND USE OF DLL4 ANTAGONIST ANTIBODIES AND ANTI-HYPERTENSIVE AGENTS

IPC classification:
A61K 31/55, A61K 31/519, A61K 31/4418, A61K 31/4184, A61K 31/401, A61K 31/341, A61K 31/166, A61K 31/138, A61P 9/12, A61P 35/00, A61K 39/395
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16157214

BIODEGRADATION PROCESS AND COMPOSITION

IPC classification:
C12N 1/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14867583

IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS

IPC classification:
A61K 38/00, C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14827185

MODIFIED SERPINS FOR THE TREATMENT OF BLEEDING DISORDERS

IPC classification:
C07K 14/81
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869059

TRANSGENIC NON-HUMAN MAMMAL EXPRESSING HUMAN MMP2

IPC classification:
C12N 15/09, A01K 67/027
Applicant:
Mie University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The patent has been granted
EP14824390

PRODUCTION OF ENCODED CHEMICAL LIBRARIES

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The patent has been granted
EP15701278

SYSTEMS AND METHODS FOR USE OF KNOWN ALLELES IN READ MAPPING

IPC classification:
C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15737117

LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF

IPC classification:
A61P 35/00, A61K 31/7034, A61K 31/724, A61K 9/127
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15737304

CYCLODEXTRIN COMPOSITIONS ENCAPSULATING A SELECTIVE ATP INHIBITOR AND USES THEREOF

IPC classification:
A61P 35/00, A61K 47/40, A61K 31/19, A61K 31/02
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15746255

GELATED IONIC LIQUID FILM-COATED SURFACES AND USES THEREOF

IPC classification:
H01M 6/22, H01M 8/18, H01M 10/0565
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15745937

ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA

IPC classification:
C12N 15/00, C12N 5/00, A61K 45/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748669

FLOWING ELECTROLYTE BATTERY SEPARATOR

IPC classification:
H01M 8/18, H01M 2/18, H01M 2/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15714426

PURIFICATION OF DNA-CONJUGATE PRODUCTS

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15768011

METHODS AND GENETIC SYSTEMS FOR CELL ENGINEERING

IPC classification:
C07H 21/04, A61K 48/00, C12N 15/74, C12N 15/87, C12N 15/00, C12N 5/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15773225

TREATMENT OF GASTRIC CANCER

IPC classification:
C07K 16/18, C07K 16/22, A61K 39/395
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16179276

METHOD FOR TREATING MULTIPLE SCLEROSIS

IPC classification:
A61P 25/00, A61K 39/395
Applicant:
Genentech, Inc.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15719362

DOSING REGIMENS FOR TREATING AND/OR PREVENTING CEREBRAL AMYLOIDOSES

IPC classification:
A61P 25/28, A61K 31/445
Agent:
Miller Sturt Kenyon Ltd
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15783784

RAPID DETERMINATION OF BACTERIAL SUSCEPTIBILITY TO AN ANTIBIOTIC AT THE POINT OF CARE

IPC classification:
C12N 1/20, C12Q 1/18, C12Q 1/04
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Agent:
Multiple attorneys, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15720177

DIAGNOSTIC METHODS FOR NEURONAL DISORDERS

IPC classification:
G01N 33/50, G01N 33/487
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15725136

ANALYSIS OF COMPOUNDS FOR PAIN AND SENSORY DISORDERS

IPC classification:
G01N 33/50
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15720856

OPTOGENETIC ANALYSIS OF COMPOUNDS

IPC classification:
G01N 33/50
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15786354

EPITHELIAL ION CHANNEL (ENAC) BLOCKERS TO TREAT PSORIASIS

IPC classification:
A61K 31/4965
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15724350

METHODS OF CANCER THERAPY

IPC classification:
A61P 35/00, A61P 35/02, A61K 31/40
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15771240

METHOD FOR TESTING COMPOUNDS ON LIVING CELLS

IPC classification:
C12N 5/00, B01L 3/00
Applicant:
University of Limerick (University of Limerick)
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15770965

MICROFLUIDIC DEVICE WITH CHANNEL PLATES

IPC classification:
B01L 3/00
Applicant:
University of Limerick (University of Limerick)
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15729557

HUMAN LIVER SCAFFOLDS

IPC classification:
A61P 1/16, A61L 27/38
Applicant:
UCL Business plc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15728120

COLLAGEN BIOMATERIALS

IPC classification:
A61L 27/52, A61L 27/24
Applicant:
UCL Business plc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818477

COMPOSITIONS AND METHODS FOR SITE-DIRECTED DNA NICKING AND CLEAVING

IPC classification:
C07H 21/00, C12N 15/00, C12N 9/16, C12P 19/34
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15822359

GALECTIN IMMUNOTHERAPY

IPC classification:
A61P 37/02, A61K 39/395, A61K 38/17
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15809732

COMPOSITIONS AND METHODS FOR THE EXPRESSION OF CRISPR GUIDE RNAS USING THE H1 PROMOTER

IPC classification:
C12N 9/16, C12N 15/861, C12N 15/85, C12N 15/79, C12N 15/63
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15745078

MAGNETIC ANASTOMOSIS DEVICES AND METHODS OF DELIVERY

IPC classification:
A61B 17/11
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15744195

ANTIBODIES FOR TREATMENT AND DIAGNOSIS

IPC classification:
C07K 16/18
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15744198

ANTI-COLLAGEN ANTIBODIES FOR TREATMENT AND DIAGNOSIS

IPC classification:
A61K 39/395, G01N 33/53, C07K 16/18
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15832300

RSPO1 BINDING AGENTS AND USES THEREOF

IPC classification:
C07K 16/28, A61P 35/00, A61K 39/395
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836791

COMBINATION THERAPY FOR TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/337, A61K 39/395, A61K 38/17
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15838545

CORNEAL ENDOTHELIAL CELL MARKER

IPC classification:
A61L 27/00, C12Q 1/68, C12N 15/09, C12N 5/10
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15838358

ACTIVATION OF MARROW INFILTRATING LYMPHOCYTES IN HYPOXIC ALTERNATING WITH NORMOXIC CONDITIONS

IPC classification:
A61K 35/28, A61P 35/00, A61K 35/17
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15840263

STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION

IPC classification:
A61K 38/54, A61K 38/24, A61K 38/17
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15841837

TREATMENT OF FIBROTIC DISEASES

IPC classification:
A61K 39/395
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16204809

PVRIG BINDING AGENTS THAT MODULATE THE HIPPO PATHWAY AND USES THEREOF

IPC classification:
A61K 45/06, A61K 38/17, C07K 16/28, C12Q 1/02, A61P 35/00, A61K 38/00, A61K 39/395
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The application has been published
EP15852140

METHODS FOR NUCLEIC ACID ASSEMBLY

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15797885

MODIFIED HETEROCYCLASE

IPC classification:
C12N 9/00
Applicant:
University Court Of The University Of Aberdeen - Research and Innovation
Applicant:
The University Court of the University of St. Andrews
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15865074

CELL AND TISSUE CULTURE CONTAINER

IPC classification:
A61L 27/38, C12Q 1/02, B01L 3/00, C12M 3/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP14908246

METHODS AND SYSTEMS FOR AUTOINDUCTION OF PROTEIN EXPRESSION

IPC classification:
C12N 15/64, C12N 15/63, C12N 15/79, C12N 15/70
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16735275

NEOCARTILAGE CONSTRUCTS USING UNIVERSAL CELLS

IPC classification:
A61L 27/38, A61L 27/56, A61K 38/39, A61K 35/32, A61L 27/24, C12N 5/0775, A61L 27/54
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15821000

ANTI-PD-1 ANTIBODIES

IPC classification:
C07K 16/28
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16735360

FACTORS AND CELLS THAT PROVIDE FOR INDUCTION OF BONE, BONE MARROW, AND CARTILAGE

IPC classification:
A61K 35/28, C12N 5/0775
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16708750

SOLID ORAL DOSAGE FORMS

IPC classification:
A61K 47/50, A61K 9/20, A61K 9/48, A61K 47/18, A61K 47/14, A61K 47/12, A61K 47/10, A61K 38/00, A61K 9/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16706691

HYDROGEL COMPRISING A SCAFFOLD MACROMER CROSSLINKED WITH A PEPTIDE AND A RECOGNITION MOTIF

IPC classification:
C12Q 1/37, A61K 47/10, A61K 9/06, A61K 38/00, A61K 47/50
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16744131

MODULATORS OF PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF

IPC classification:
C12Q 1/42, C12N 9/16
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP17170499

WNT ANTAGONISTS AND METHODS OF TREATMENT

IPC classification:
C07K 14/705, C12N 5/10, C12N 15/12, A61K 38/17
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The application has been published
EP16710332

MICROBIAL CONSORTIA

IPC classification:
C12R 1/00, A01N 63/00, C05F 1/00, C05F 11/08, C12N 1/20, C12N 1/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16710814

MICROBIAL CONSORTIA

IPC classification:
C12R 1/00, A01N 63/00, C05F 1/00, C05F 11/08, C12N 1/20, C12N 1/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16710333

MICROBIAL CONSORTIA

IPC classification:
A01N 63/00, C12N 1/20, C12N 1/14, C05F 1/00, C05F 11/08
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16765510

LTB4 INHIBITION TO PREVENT AND TREAT HUMAN LYMPHEDEMA

IPC classification:
C40B 30/04, A61K 31/19, A61P 7/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16735337

SCREENING FOR STRUCTURAL VARIANTS

IPC classification:
G06F 19/22, G06F 19/18, C12N 9/22, C12N 9/00, C12Q 1/68
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16737857

METHODS OF QUALITY CONTROL USING SINGLE-NUCLEOTIDE POLYMORPHISMS IN PRE-IMPLANTATION GENETIC SCREENING

IPC classification:
G06F 19/22, C12Q 1/68
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16765585

SYSTEMS AND METHODS FOR ANALYZING NUCLEIC ACID

IPC classification:
C12Q 1/68, G06F 19/18
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP17701045

BINDING MEMBERS WITH ALTERED DIVERSITY SCAFFOLD DOMAINS

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16718812

EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III-MESOTHELIN FUSIONS AND METHODS OF USING THE SAME

IPC classification:
C12N 15/62, A61K 39/00, C07K 14/735
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16768689

THERAPEUTIC AGENT ASSOCIATED WITH SUPPRESSION OF PROLIFERATION AND METASTASIS OF TUMOR, WHICH COMPRISES EXOSOMES RELEASED FROM CYTOTOXIC T CELLS AND TARGETS CANCER STROMAL/MESENCHYMAL CELLS

IPC classification:
C12N 5/078, A61P 43/00, A61P 35/04, A61P 35/00, A61K 31/7105, A61K 9/08, A61K 35/17
Applicant:
Mie University
Applicant:
Kyoto University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16783931

COMPOSITIONS AND METHODS RELATED TO CHARACTERIZING PROVIRAL RESERVOIRS

IPC classification:
C12N 15/48, C12N 15/33, C12N 15/09, C12Q 1/68
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16737776

DEVICES AND SYSTEMS FOR BARCODING INDIVIDUAL WELLS AND VESSELS

IPC classification:
G06K 19/06, B01L 3/00, G01N 35/00
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16723969

IL2 AND TNF IMMUNOCONJUGATES

IPC classification:
A61P 35/00, C07K 19/00, C07K 16/18, C07K 14/55, C07K 14/525
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16797384

OPTOGENETICS MICROSCOPE

IPC classification:
G02B 21/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16724216

SYSTEMS, DEVICES, AND METHODS FOR FORMING ANASTOMOSES

IPC classification:
A61B 17/00, A61B 17/11
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16732328

IN VITRO PRODUCTION OF CHOLANGIOCYTES

IPC classification:
G01N 33/50, A61K 35/413, C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16736612

ANTI-VISTA ANTIBODIES AND FRAGMENTS

IPC classification:
C07K 16/28
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16818647

IMMUNE CHECKPOINT CHIMERIC ANTIGEN RECEPTORS THERAPY

IPC classification:
A61P 35/00, A61K 38/17, C07K 14/725, C07K 14/705, C12N 15/62, C07K 19/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16747615

MECHANICAL DEVICE FOR GENERATING COMBINATORIAL LIBRARY

IPC classification:
B01L 3/00, B01F 13/00, B01J 19/00, C40B 60/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16774977

SINGLE USE DELIVERY DEVICE PREFILLED WITH A RECONSTITUTABLE AGENT

IPC classification:
A61M 39/24, A61M 5/32, A61M 5/30, A61J 1/20, A61M 5/24
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16758263

SINGLE USE DELIVERY DEVICE HAVING SAFETY FEATURES

IPC classification:
A61M 39/02, A61M 5/28
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16757930

SINGLE USE DELIVERY DEVICE

IPC classification:
A61M 5/32, A61M 5/28
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16818953

CRISPR/CAS9-BASED TREATMENTS

IPC classification:
A61P 27/02, A61K 48/00, C12N 9/22, C12N 15/90, C12N 15/113, C12N 15/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16822042

MARROW INFILTRATING LYMPHOCYTES (MILS) AS A SOURCE OF T-CELLS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPY

IPC classification:
A61K 38/17, C07K 19/00, C12N 5/10, C12N 5/078
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16750213

METHODS AND DEVICES FOR THE PRODUCTION OF DECELLULARISED TISSUE SCAFFOLDS

IPC classification:
C12M 1/33, B01L 3/00, A61L 27/36, C12N 5/071
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16750437

INSULIN-LIKE GROWTH FACTOR 2 (IGF2) BINDING AGENTS

IPC classification:
C12N 15/63, A61K 38/17, C07K 14/435
Applicant:
Cancer Research Technology Ltd
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16841816

ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASES BY USING ROR1-POSITIVE MESENCHYMAL STEM CELLS

IPC classification:
A61P 43/00, A61P 35/00, A61P 19/00, A61P 9/00, A61P 3/00, A61P 1/18, A61P 1/16, A61P 1/00, A61K 35/28, C12N 5/0775
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16844963

BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS

IPC classification:
C12N 5/07, C12N 5/071, C12N 15/00, A61K 48/00
Applicant:
The University of Washington
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16849686

METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER

IPC classification:
A61K 39/395, A61K 31/282, C07K 16/46, C07K 16/28, C07K 16/22
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP17205290

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER

IPC classification:
C12N 15/00, C07H 21/04, C12P 21/08, C07K 16/00, A61K 39/395, C07K 16/30
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Dirk B├╝hler, Maiwald Patentanwalts GmbH
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The application has been published
EP16852701

BI-SPECIFIC THERAPEUTIC PROTEINS FOR TISSUE REPAIR

IPC classification:
C07K 14/65, C07K 14/00, C12N 15/62, A61P 43/00, A61K 38/16
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP17206538

METHODS AND DEVICES FOR NUCLEIC ACIDS SYNTHESIS

IPC classification:
C12P 19/34, C12N 15/66, C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The application has been published
EP16858264

IMPROVED METHODS AND DEVICES FOR ACCURATE DIAGNOSIS OF INFECTIONS

IPC classification:
G01N 30/90, G01N 33/68, G01N 33/569, C12Q 1/04
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16782213

METHODS OF T-LYMPHOCYTE EXPANSION

IPC classification:
A61K 35/12, A01K 67/027, C12N 5/0783
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16863046

METHODS OF TREATING LIVER FIBROSIS BY ADMINISTERING 3-BROMOPYRUVATE

IPC classification:
A61P 1/16, A61K 31/19
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16865071

CELL-PENETRATING, GUANIDINIUM-RICH OLIGOPHOSPHOTRIESTERS FOR DRUG AND PROBE DELIVERY

IPC classification:
C07H 21/00, A61K 48/00, A61K 47/50
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature